US Stock MarketDetailed Quotes

TherapeuticsMD (TXMD)

Watchlist
  • 2.190
  • +0.010+0.46%
Close Apr 24 16:00 ET
25.35MMarket Cap-43.80P/E (TTM)

TherapeuticsMD (TXMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
71.61%3.02M
33.88%893K
43.33%784K
306.84%952K
25.56%393K
35.25%1.76M
32.87%667K
1,132.08%547K
-46.45%234K
-24.76%313K
Operating revenue
71.61%3.02M
33.88%893K
43.33%784K
306.84%952K
25.56%393K
35.25%1.76M
32.87%667K
1,132.08%547K
-46.45%234K
-24.76%313K
Cost of revenue
Gross profit
1,132.08%547K
-46.45%234K
Operating expense
9.55%7.24M
82.09%2.39M
-3.99%1.61M
-6.53%1.65M
-19.18%1.18M
-32.77%6.61M
-37.91%1.31M
-2.27%1.68M
-39.43%1.76M
-52.81%1.46M
Selling and administrative expenses
12.40%6.85M
89.11%2.29M
-4.23%1.52M
-1.96%1.55M
-18.23%1.08M
-31.53%6.1M
-17.89%1.21M
-0.31%1.59M
-43.11%1.58M
-56.74%1.32M
-General and administrative expense
12.40%6.85M
89.11%2.29M
-4.23%1.52M
----
----
--6.1M
--1.21M
--1.59M
----
----
Depreciation amortization depletion
-24.56%384K
-3.00%97K
0.00%96K
-46.67%96K
-28.57%95K
-44.79%509K
-84.30%100K
-26.15%96K
40.63%180K
392.59%133K
-Depreciation and amortization
-24.56%384K
-3.00%97K
0.00%96K
-46.67%96K
-28.57%95K
-44.79%509K
-84.30%100K
-26.15%96K
40.63%180K
392.59%133K
Operating profit
13.01%-4.21M
-131.94%-1.5M
26.81%-830K
54.52%-695K
31.44%-783K
43.17%-4.84M
59.96%-645K
36.04%-1.13M
38.19%-1.53M
57.18%-1.14M
Net non-operating interest income expense
5.19%142K
4.20%149K
0.00%-3K
60.00%-2K
-2K
135K
143K
85.00%-3K
88.89%-5K
0
Non-operating interest income
5.19%142K
----
----
----
----
--135K
----
----
----
----
Non-operating interest expense
----
----
0.00%3K
-60.00%2K
--2K
----
----
-85.00%3K
-88.89%5K
--0
Other net income (expense)
44.51%3.42M
31.11%767K
54.91%883K
157.14%1.24M
-64.86%117K
202.94%2.37M
764.77%585K
58.77%570K
368.93%483K
-18.18%333K
Special income (charges)
86.12%-176K
-700.00%-56K
---32K
--0
---88K
---1.27M
---7K
--0
---1.26M
--0
-Less:Impairment of capital assets
-86.12%176K
700.00%56K
--32K
--0
--88K
--1.27M
--7K
--0
--1.26M
--0
-Write off
----
----
----
--0
----
----
----
----
--0
----
Other non- operating income (expenses)
-1.07%3.6M
39.02%823K
60.53%915K
-28.78%1.24M
-38.44%205K
365.30%3.63M
772.73%592K
58.77%570K
1,593.20%1.74M
-18.18%333K
Income before tax
72.13%-653K
-798.80%-580K
108.82%50K
151.90%545K
17.43%-668K
69.74%-2.34M
105.24%83K
60.46%-567K
56.50%-1.05M
64.98%-809K
Income tax
0
203.23%32K
0
0
-32K
27.91%-31K
27.91%-31K
0
0
0
Net income
73.91%-569K
-345.63%-619K
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
Net income continuous Operations
71.76%-653K
-636.84%-612K
108.82%50K
151.90%545K
21.38%-636K
69.97%-2.31M
107.40%114K
60.46%-567K
56.50%-1.05M
64.98%-809K
Net income discontinuous operations
-35.88%84K
-105.07%-7K
342.86%102K
115.00%6K
-122.67%-17K
105.08%131K
-79.03%138K
97.84%-42K
---40K
105.80%75K
Minority interest income
Net income attributable to the parent company
73.91%-569K
-345.63%-619K
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
73.91%-569K
-345.63%-619K
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
Basic earnings per share
73.68%-0.05
-350.00%-0.05
120.00%0.01
155.56%0.05
0.00%-0.06
80.61%-0.19
133.33%0.02
84.38%-0.05
62.50%-0.09
83.78%-0.06
Diluted earnings per share
73.68%-0.05
-350.00%-0.05
120.00%0.01
155.56%0.05
0.00%-0.06
80.61%-0.19
133.33%0.02
84.38%-0.05
62.50%-0.09
83.78%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 71.61%3.02M33.88%893K43.33%784K306.84%952K25.56%393K35.25%1.76M32.87%667K1,132.08%547K-46.45%234K-24.76%313K
Operating revenue 71.61%3.02M33.88%893K43.33%784K306.84%952K25.56%393K35.25%1.76M32.87%667K1,132.08%547K-46.45%234K-24.76%313K
Cost of revenue
Gross profit 1,132.08%547K-46.45%234K
Operating expense 9.55%7.24M82.09%2.39M-3.99%1.61M-6.53%1.65M-19.18%1.18M-32.77%6.61M-37.91%1.31M-2.27%1.68M-39.43%1.76M-52.81%1.46M
Selling and administrative expenses 12.40%6.85M89.11%2.29M-4.23%1.52M-1.96%1.55M-18.23%1.08M-31.53%6.1M-17.89%1.21M-0.31%1.59M-43.11%1.58M-56.74%1.32M
-General and administrative expense 12.40%6.85M89.11%2.29M-4.23%1.52M----------6.1M--1.21M--1.59M--------
Depreciation amortization depletion -24.56%384K-3.00%97K0.00%96K-46.67%96K-28.57%95K-44.79%509K-84.30%100K-26.15%96K40.63%180K392.59%133K
-Depreciation and amortization -24.56%384K-3.00%97K0.00%96K-46.67%96K-28.57%95K-44.79%509K-84.30%100K-26.15%96K40.63%180K392.59%133K
Operating profit 13.01%-4.21M-131.94%-1.5M26.81%-830K54.52%-695K31.44%-783K43.17%-4.84M59.96%-645K36.04%-1.13M38.19%-1.53M57.18%-1.14M
Net non-operating interest income expense 5.19%142K4.20%149K0.00%-3K60.00%-2K-2K135K143K85.00%-3K88.89%-5K0
Non-operating interest income 5.19%142K------------------135K----------------
Non-operating interest expense --------0.00%3K-60.00%2K--2K---------85.00%3K-88.89%5K--0
Other net income (expense) 44.51%3.42M31.11%767K54.91%883K157.14%1.24M-64.86%117K202.94%2.37M764.77%585K58.77%570K368.93%483K-18.18%333K
Special income (charges) 86.12%-176K-700.00%-56K---32K--0---88K---1.27M---7K--0---1.26M--0
-Less:Impairment of capital assets -86.12%176K700.00%56K--32K--0--88K--1.27M--7K--0--1.26M--0
-Write off --------------0------------------0----
Other non- operating income (expenses) -1.07%3.6M39.02%823K60.53%915K-28.78%1.24M-38.44%205K365.30%3.63M772.73%592K58.77%570K1,593.20%1.74M-18.18%333K
Income before tax 72.13%-653K-798.80%-580K108.82%50K151.90%545K17.43%-668K69.74%-2.34M105.24%83K60.46%-567K56.50%-1.05M64.98%-809K
Income tax 0203.23%32K00-32K27.91%-31K27.91%-31K000
Net income 73.91%-569K-345.63%-619K124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K
Net income continuous Operations 71.76%-653K-636.84%-612K108.82%50K151.90%545K21.38%-636K69.97%-2.31M107.40%114K60.46%-567K56.50%-1.05M64.98%-809K
Net income discontinuous operations -35.88%84K-105.07%-7K342.86%102K115.00%6K-122.67%-17K105.08%131K-79.03%138K97.84%-42K---40K105.80%75K
Minority interest income
Net income attributable to the parent company 73.91%-569K-345.63%-619K124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 73.91%-569K-345.63%-619K124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K
Basic earnings per share 73.68%-0.05-350.00%-0.05120.00%0.01155.56%0.050.00%-0.0680.61%-0.19133.33%0.0284.38%-0.0562.50%-0.0983.78%-0.06
Diluted earnings per share 73.68%-0.05-350.00%-0.05120.00%0.01155.56%0.050.00%-0.0680.61%-0.19133.33%0.0284.38%-0.0562.50%-0.0983.78%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More